RNA interference (RNAi) is a valuable tool in biological studies, as it enables the selective, transient knockdown of protein expression [7, 9, 37] . The RNAi mechanism is based on the strongly conserved post-transcriptional gene silencing function mediated by double-stranded molecules [10, 32] . There are two types of RNAi mechanisms: RNAbased RNAi and DNA-based RNAi. In RNA-based RNAi, a synthetic short-interfering RNA (siRNA) duplex is introduced into the cells. In DNA-based RNAi, a plasmid carrying sequences encoding short-hairpin RNA (shRNA) is delivered to the cells [37] . The siRNA method, which transiently blocks protein expression, can be achieved by delivering synthetic double-stranded RNA into cells. siRNA is incorporated into a RNA-induced silencing complex (RISC) that causes the sequence-specific degradation of the corresponding mRNA [4, 47] . siRNA is also produced by the delivery of a plasmid encoding a shRNA that generates the 21 mer nucleotides of siRNA [33] . Compared with siRNA, shRNA leads to a long-term gene silencing effect. Thus, the plasmid DNA system is effective for generating stable RNAi in target cells.
For shRNA expression, a RNA polymerase III (PolIII) promoter is used to transcribe shRNA that contains a doublestranded stem of 19-25 bp with sequences complementary to the target gene, and a 5-10 base loop sequence connecting them [31] . shRNAs can be effectively transcribed in mammalian cells by PolIII promoters, such as U6 and H1 [5, 33, 35, 40] . The human U6 promoter is composed of a TATA-like element located approximately 30 bp upstream of the transcription initiation site and a proximal sequence element (PSE) located upstream of the TATA box [26] . A distal sequence element (DSE) located further upstream from the PSE enhances transcription from the core promoter [25] . This promoter has been widely used in mammalian systems for the expression of shRNA [6, 14] . The use of the Drosophila melanogaster U6 promoter for shRNA expression has been characterized, and the critical TATA-like element and the PSE have been identified [18] . The shRNAs transcribed from the Drosophila U6 promoter can efficiently trigger gene silencing in Drosophila S2 cells [44] .
Since insect cells have the ability to efficiently perform many eukaryotic post-translational modifications, several insect cells are used for recombinant glycoprotein expression using a baculovirus expression system [20, 22, 41, 42] . Spodoptera frugiperda (Sf9) and Trichoplusia ni (T. ni) cell lines are the most widely used baculovirus-insect cell systems [24] . However, glycoproteins produced by insect cells are significantly different from those produced by mammalian cells, as insect cells lack the ability to synthesize complex type N-glycans with a complete sialylated antenna as found in mammalian glycoproteins. One of the main reasons for this difference is that insect cells express β-Nacetylglucosaminidase (GlcNAcase), which prevents the terminal extension of N-glycans by galactosyltransferases and sialytransferases [1] . Watanabe et al. [45] suggested that the suppression of intrinsic GlcNAcase activity with a specific inhibitor, 2-acetoamido-1,2-dideoxynojirimycin (2-ADN), allowed the further elongation of N-glycan to form sialylated N-glycan in insect cells after baculovirus infection. Alternatively, GlcNAcase was suppressed using double-stranded RNA (dsRNA) in Drosophila S2 cells and in Sf9 cells [12, 21] ; however, the suppression of GlcNAcase expression using RNAi has not been reported in T. ni cells, the most widely used cell line for the expression of mammalian glycoproteins.
Recently, in-vitro-produced dsRNA was tested in T. ni larvae as a potential tool for the metabolic engineering of protein expression systems [23] and a 600 bp dsRNA was employed to suppress the expression of Tn-caspase-1 in order to enhance the production of a recombinant protein in a T. ni-derived cell line using the baculovirus expression vector system [15] . However, the use of an shRNA-based RNA interference system has not been established in T. ni cells.
Our initial study showed that the activity of the reporter genes luciferase and green fluorescent protein (GFP) was successfully suppressed after the introduction of specific shRNA under the control of the human U6 promoter in T.
ni cells. We used the human and Drosophila U6 promoters to express shRNAs in T. ni cells and compared their efficiency. Our results showed that the expression of shRNAs using these two promoters exhibited the potential to be used for the specific knockdown of target genes in T. ni cells. Finally, inhibition of GlcNAcase activity was achieved by using the shRNA expression system in T. ni cells, demonstrating the use of an shRNA-mediated interference system in T. ni cells for the first time.
MATERIALS AND METHODS
shRNA Expression System A RNA polymerase III promoter-based shRNA vector was constructed as described before [5, 40] . The hygromycin gene under the control of an SV40 promoter was removed from the pSilencer2.1 hygro vector (Ambion, Austin, TX, USA) and the resulting plasmid was designated to the shRNA vector containing a human U6 promoter (pSil/HU6). To compare the human and Drosophila U6 promoters, the Drosophila U6 promoter-based shRNA expression vector was constructed as follows. The Drosophila U6 promoter was amplified by PCR using the genomic DNA isolated from Drosophila as template, and the primers D62F (5'-tagaattcgttcgacttgcagcctga-3') and D62R (5'-ccggatccacgaagtattgaggaaaa-3'). The PCR product was separated on a 1% agarose gel by electrophoresis and then extracted from the gel. The human U6 promoter was removed from the pSil/HU6 and the Drosophila U6 promoter was inserted into the corresponding site (pSil/DU6). siRNA-encoding DNA oligonucleotides targeting firefly luciferase, GFP, and GlcNAcase at different locations (Table 1) were synthesized and inserted into a HindIII-BamHI linearized pSil/HU6 or pSil/DU6 vector according to the manufacturer's instructions. The zeocin-resistant gene fused to GFP was inserted into the pSil/HU6 or pSil/DU6 vectors for the construction of stable T. ni cells expressing shRNAs (pSil/HU6-Zeo-GFP or pSil/DU6-Zeo-GFP). The GFP-expressing transgenic T. ni cell line (T. ni/GFP cells) was constructed as follows. T. ni cells were transfected with a GFPexpressing vector (pIZT vector; Invitrogen, Carlsbad, CA, USA) and siRNA Detection Detection of antiluciferase siRNAs was accomplished by performing an RNase protection assay on pSil/HU6/luci or pSil/DU6/luci transfected T. ni cells. Small RNAs were isolated using the mirVana miRNA isolation kit (Ambion, Austin, TX, USA). The 33 nt RNA oligonucleotide (Luci RNA probe, 5'-GUUCGUCACAUCUCA UCUACCNNNNNNNNNN-3') containing the 21 nt luciferase target sequence ( Table 1) followed by using the mirVana Probe and Marker kit (Ambion, Austin, TX, USA). The radio-labeled probe was hybridized at 42 o C for 4 h with miRNA, and RNase was treated using the mirVana miRNA detection kit (Ambion, Austin, TX, USA). The RNA fragments were run on a denaturing 15% TBEurea PAGE. The hybrid RNA was detected by autoradiography.
GlcNAcase Activity Assay
The T. ni cells were transfected with 2 µg of pSil/HU6/GlcNAcase A, B, or C. At 48 h post transfection, the cells were harvested, washed, and lysed with phosphate-buffered saline (pH 6.2). The cells were lysed in 1 ml of phosphate-buffered saline containing 1% (v/v) Triton X-100. After centrifugation for 10 min at 10,000 ×g, the supernatants were used for the GlcNAcase assay. The supernatants (50 µl) were mixed with 200 µl of substrate solution (1 mg/ml pnitrophenyl-β-D-N-acetylglucosaminide in 0.2 M citrate phosphate buffer, pH 4.0), and the mixture was incubated for 1 h at 37 o C. The reaction was stopped by the addition of 2 ml of 1 M Na
, and its absorbance at 405 nm was then measured.
Quantitative Real-Time PCR The GlcNAcase mRNA expression level was quantified by real-time RT-PCR. RNAs were extracted from the untransfected and pSil/ HU6/GlcNAcase-transfected T. ni cells. RNA solution (10 µl) was added to a RT-premix (Bioneer, Daejeon, Korea) containing 10 units of MLV-RT, enzyme buffer, 10 mM dNTP mixture, and 10 pmol of oligo(dT). First-strand cDNA was synthesized at 42 o C for 60 min. Then, 1 µl of the RT reaction mixture was amplified by PCR using an EX-Taq premix (TaKaRa, Seoul, Korea) with NAcase F (5'-atgtggcttcaaagattt-3') and NAcase 1100R (5'-ctccacacagtaatgtgacc-3') primers. The nested PCR was performed using an EX-Taq SYBR premix (TaKaRa, Seoul, Korea) with NAcase 900F (5'-gttaggtgctctcacaccagc-3') and 1100R (5'-ctccacacagtaatgtgacc-3') as primers. GlcNAcase gene specific PCR products were continuously measured using an ABIPrism5700 Sequence Detection System (Applied Biosystems, Foster, CA, USA) during the 50 cycles of PCR. For the normalization of endogenous gene, PCR targeting actin was performed with T. ni actin F (5'-acgagaccacctacaactcgat-3') and actin R (5'-cctggtgtagggcatcataaat-3') as primers.
Statistical Analysis
Statistical comparisons between the control and each treated group were done using the unpaired Student's t-test. Differences were considered significant at P < 0.05. All experiments were performed at least three times, providing similar results.
RESULTS

shRNA-Mediated Interference of Exogenous Gene Expression
Whereas synthetic dsRNA has been employed to suppress specific gene expression in order to enhance the production of recombinant proteins in a T. ni-derived cell line [15] , a shRNA-based RNA interference system has not been established in T. ni cells. To examine whether the shRNA approach can be applied to specifically inhibit gene expression in T. ni cells, we used shRNA expression vectors containing the human U6 promoter (pSilencer2.1 hygro; Ambion). Our initial attempt to investigate shRNAbased RNA interference in T. ni cells was performed against luciferase, a widely used reporter gene equipped with a well-established assay system. shRNA targeting the luciferase coding DNA sequence was designed to have two inverted 21 nt sequences to generate the stem structure that was separated by a 9 nt sequence to form the loop region (Fig. 1A) .
T. ni cells transfected with pSil/HU6 vector or pSil/ HU6/luci were incubated for 24 h and transfected with the pGL3/gp64 and pRL/actin 5c vectors. At 48 h post transfection of pGL3/gp64 and pRL/actin 5c vectors, the luciferase activity was assayed by a luminometer. As shown in Fig. 1B , the luciferase activity of T. ni cells transfected with the pSil/HU6/luci vectors were inhibited in a dosedependent manner, whereas transfection with the pSil/HU6 empty vector had no deleterious effect on luciferase expression (Fig. 1B, control) . In the cells transfected with 2 µg of pSil/HU6/luci, the luciferase expression level was reduced by 70% as compared with the control cells. These results suggest that the shRNA-based RNAi under the control of the human U6 promoter efficiently interfered with the specific expression of luciferase in T. ni cells.
Construction of the shRNA Expression Vector Containing the Drosophila U6 Promoter
The critical TATA-like element and PSE of the Drosophila U6 promoter have been identified [18] , and shRNAs transcribed from the Drosophila U6 promoter can efficiently trigger gene silencing in Drosophila S2 cells [44] . We assumed that the Drosophila U6 promoter would be more activated than the human U6 promoter in T. ni cells. In order to examine if the Drosophila U6 promoter could be applied for shRNA-mediated gene interference in T. ni cells, DNA spanning the entire region of the U6 promoter was cloned from Drosophila genomic DNA. Alignment and analysis of the nucleotide sequences of this promoter revealed that the TATA box and PSE were well conserved with the insect PolIII consensus sequences ( Fig. 2 ; [18, 38] ).
The human U6 promoter region in pSil/HU6 was replaced with the Drosophila U6 promoter to construct the pSil/DU6 vector (Supplemental Fig. 1 ). To generate stable transgenic insect cell lines, the hygromycin resistance gene (SV40 promoter-hygromycin) was removed and a zeocin resistance gene fused to GFP was inserted at the corresponding site to generate pSil/HU6-Zeo-GFP or pSil/DU6-Zeo-GFP (Supplemental Fig. 1 ). For the efficient expression of shRNA in the insect cell line, the mammalian cell-specific SV40 promoter was replaced with the insect cell-derived OpiE1 promoter, and for cloning convenience, HindIII and BamHI sites were introduced next to the U6 promoter (Supplemental Fig. 1 ).
Comparison of Human and Drosophila U6 Promoters in shRNA-Mediated Inhibition The human U6 promoter has been widely used in shRNA expression vectors in many different types of cells [5, 30] , including T. ni cells (Fig. 1B) . Recent reports indicated that promoter choice is critical to achieve high levels of shRNA-based interference [46] . In order to establish an effective shRNA interference system in T. ni cells, we evaluated the efficiency of the human and Drosophila U6 promoters to specifically interfere with gene expression. T. ni cells previously transfected with the pSil/HU6/luci or pSil/DU6/luci vectors (Fig. 3A) were transfected with pGL3/gp64, and the luciferase activity was analyzed at 48 hours post transfection. The human and Drosophila U6 promoter-driven shRNA showed suppression of luciferase activity when compared with the control vector-treated cells. We observed an approximately 40% reduction of luciferase activity in cells transfected with shRNA-expressing plasmids, and no significant difference in efficiency was observed between the Drosophila and human U6 promoterdriven shRNA-treated cells (Fig. 3A) . Transfection of the vector itself, pSil/HU6, did not interfere with luciferase The construction of the shRNA vector targeting luciferase (A). T. ni cells were transfected with pSil/HU6/luci in a dose-dependent manner, and pGL3/gp64-luci and pRL/actin-renilla were transfected into shRNAtransfected cells 24 h post transfection (B). Forty-eight h after transfection, cells were isolated and used for the enzyme assay. Each result represents the mean ± SD from three independent experiments. Statistically significant differences compared with the control group (*, P < 0.05).
Fig. 2. Construction of the shRNA expression vectors.
Schematic presentation of the Drosophila PolIII promoter compared with the insect PolIII consensus sequences. activity (Fig. 3A) . These results indicate that exogenously supplied luciferase gene expression was effectively inhibited by shRNA transcribed from both the human and Drosophila U6 promoters.
As we would like to develop transgenic T. ni cell lines in which endogenous gene expression is knocked down by shRNA, we constructed a GFP-expressing transgenic T. ni cell line and investigated the inhibition of GFP activity by shRNA. GFP-expressing transgenic T. ni cells were transfected with either the pSil/HU6/GFP or pSil/DU6/GFP vectors. We observed an approximately 13% reduction of GFP activity with pSil/DU6/GFP and an 8% reduction with pSil/HU6/GFP compared with control cells (Fig. 3B) . The inhibition of endogenous GFP using the shRNA expression vectors was less efficient than for exogenous luciferase because of the residual levels of endogenous GFP that were expressed prior to the transfection of GFPtargeted shRNA. The human and Drosophila U6 promoters did not show significant differences in their inhibition of exogenous and endogenous gene expressions in T. ni cells. These results suggest that the species origin of the promoter is not important in determining efficiency, and the human and Drosophila U6 promoters successfully expressed shRNA to reduce the levels of the target protein in T. ni cells.
siRNA Detection
To confirm that the observed inhibition of target gene activity was caused by the siRNA produced from the shRNA vector, an siRNA detection experiment was performed using the RNase protection assay. T. ni cells were transfected with pSil/HU6/Luci or pSil/DU6/Luci, and small RNAs were isolated from the transfected cells at 48 h post transfection using the mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA). Small RNAs were hybridized to a 5'-32 P radiolabeled probe (31 nt) containing 21 nt of the luciferase target sequence at the 5' end and 10 nt of random sequence at the 3' end ( Table 1) . Hybridization of the radiolabeled probe to the 21 nt siRNA produced from shRNA should protect the luciferase target sequence from RNaseA/T1 digestion. The 31 nt probe RNA (Fig. 4, lane 1) was completely digested after it was treated with RNaseA/T1 (Fig. 4, lane 2) . The 21 nt bands were detected using RNAs extracted from either pSil/ HU6/Luci (Fig. 4, lane 4) or pSil/DU6/Luci (Fig. 4, lane 5) transfected T. ni cells, whereas no band was detected using RNAs extracted from untransfected T. ni cells (Fig. 4, lane 3) . These results indicated that the shRNA was expressed and processed to siRNA in pSil/HU6/Luci or pSil/DU6/Luci transfected T. ni cells. Human or Drosophila U6 promoter-driven shRNA plasmids were transfected into T. ni or T. ni/GFP cells. Forty-eight h after transfection, cells were isolated and used for the enzyme assay. Each point represents the mean ± SD from three independent experiments. Statistically significant differences compared with the control group (*, P < 0.05). 
shRNA-Mediated Inhibition of GlcNAcase Expression
Protein glycosylation is one of the most critical posttranslational modifications in eukaryotes, as the patterns of covalently linked glycans can influence protein function in many different ways [43] . Failure to express glycoproteins in the terminally sialylated form resulted in the limited use of the baculovirus-insect cell expression system for the production of mammalian cell-derived glycoproteins [2, 16, 17] . GlcNAcase removes the terminal GlcNAc residue from GlcNAcMan 3 GlcNAc 2 -N-Asn and eliminates the intermediate required for terminal sialylation to produce complex N-glycans [12, 21] .
As knockdown of GlcNAcase in insect cells would promote the production of glycans that can eventually be the precursors for sialylation, we attempted to knock down GlcNAcase activity in T. ni cells using siRNA-based RNA interference. Three siRNA sequences targeting the GlcNAcase RNA were selected using the RNAi Explore (http://www.genelink.com) computer program ( Table 1) . The three types of siRNA were chemically synthesized and 600 nM of each siRNA was transfected into T. ni cells. The cells were harvested at 48 h post-transfection and GlcNAcase activity was analyzed. All three siRNAs interfered with GlcNAcase activity, and we observed an approximately 30% reduction of activity in comparison with the control transfected cells (Fig. 5A ). GlcNAcase activity in T. ni cells transfected with increasing amounts of siRNA was gradually reduced, indicating the interference occurred in a dose-dependent manner (Fig. 5B) .
To construct the transgenic T. ni cell line that stably expressed siRNA against GlcNAcase, we constructed three plasmids carrying the cDNA encoding the corresponding shRNAs under the control of the human U6 promoter. The oligonucleotide sequences encoding the shRNAs for GlcNAcase are described in Table 1 . These plasmids were transfected into T. ni cells and their effects on GlcNAcase activity levels were determined in comparison with control vector-treated cells. All three shRNAs were used under identical conditions, and we transfected 2 µg of plasmid per 3.0 × 10 5 cells. As shown in Fig. 5C , GlcNAcase activity was suppressed by shRNA B to 15% of the level of control vector-treated cells. No significant difference in GlcNAcase suppression efficiency was observed between the human and Drosophila U6 promoter-driven shRNA-treated cells (Fig. 5D) .
Effect of GlcNAcase shRNA on GlcNAcase mRNA Levels To confirm that the shRNA mediated its effect by the specific knockdown of GlcNAcase mRNA, we tested The comparison of GlcNAcase suppression using human and Drosophila U6 promoter-driven shRNA in T. ni cells. Forty-eight h after transfection, cells were isolated and used for the enzyme assay. Each result represents the mean ± SD from three independent experiments. Statistically significant differences compared with the control group (*, P < 0.05).
mRNA levels using real-time PCR. For this experiment, total RNA was extracted and real-time quantitative RT-PCR was performed with GlcNAcase-specific primers. As shown in Fig. 6 , the GlcNAcase mRNA level was down-regulated following transfection with 2 µg of pSil/ HU6/GlcNAcase A, B, or C as compared with the control vector-treated cells. Consistent with the observation that GlcNAcase activity was most effectively suppressed by shRNA B (Fig. 5C ), pSil/HU6/GlcNAcase B was more effective at the down-regulation of GlcNAcase mRNA than either pSil/HU6/GlcNAcase A or C. Therefore, our result is consistent with other studies in that the use of shRNA represents an effective strategy to knock down gene expression in a highly specific manner.
DISCUSSION
In this study, we established an RNAi-based gene expression interference system in T. ni cells. Long dsRNAs are known to be ineffective for gene expression interference because they also induce a nonspecific inhibitory response in mammalian cells [7, 9] ; however, 21-23 bp siRNAs effectively inhibit gene expression in mammalian cells. This process has emerged as an effective strategy to selectively silence gene expression. Although siRNA is a convenient method for blocking specific protein expression, chemically synthesized siRNA is not stable in the cellular environment. Therefore, vector-based RNAi (shRNA) could function as an alternative method for gene silencing. In addition, the shRNA hairpin has been established as a better substrate for dicer and displays improved RISC loading [34, 39] . The expression of shRNA from DNA-based vectors offers many advantages over chemically synthesized siRNA molecules, such as the capability for amplification and less susceptibility to intracellular degeneration.
In order to achieve specific target gene silencing, we initially applied DNA vector-based strategies for the delivery of siRNA into T. ni cells. The activity of luciferase, an exogenously supplied reporter gene, was significantly reduced after introducing a plasmid producing shRNA designed to target luciferase mRNA ( Fig. 1 and Fig. 3A) . Since it would be more relevant to examine if shRNA can inhibit the expression of an endogenous gene, we constructed a transgenic T. ni cell line stably expressing GFP (T. ni/GFP). GFP activity was inhibited in T. ni/GFP cells after transfection with pSil/HU6/GFP or pSil/DU6/GFP carrying shRNA targeting GFP-encoding DNA (Fig. 3B) . Since the GFP that was expressed prior to the introduction of the siRNA-producing plasmid would not be inhibited, we observed a much lower level of inhibition for endogenous GFP (13%) compared with the inhibition of the exogenous luciferase (70%). An RNase protection assay conducted with RNA extracted from T. ni cells transfected with pSil/ HU6/luci or pSil/HU6/luci indicated that shRNA was produced under the control of either the HU6 or DU6 promoter and that siRNA was processed in T. ni cells (Fig. 4) .
In order to express shRNA, a PolIII promoter, including human and mouse U6, is widely used. Promoters of this type are preferred because they have a simple structure, a well-defined transcription start site, and they naturally drive the transcription of small RNA [11, 38] . Research into promoters for shRNA has been mainly conducted using mammalian cells, and insect cells have been rarely employed. Since the purpose of our study was to construct an efficient shRNA expression system in insect cells, we systemically compared human and Drosophila promoters for specific gene silencing in T. ni cells. We did not observe any significant difference between constructs that differed in only their promoter (Fig. 3 and Fig. 5D ).
The PSE and TATA sequences of our Drosophila U6 promoter are conserved with the insect consensus sequences (Fig. 2) . The Drosophila PSE is apparently homologous to the vertebrate PSE in that it is required for a basal level of transcription [29, 48] . The U6 genes, which are transcribed by PolIII, contain a TATA box and a PSE, and the TATA box acts as a dominant element for the selection of PolIII. The PSEs of the PolII-and PolIII-transcribed snRNA genes can be exchanged without affecting the specificity of RNA polymerase [8, 27, 28] . The TATA sequences of the human and Drosophila U6 promoters are also conserved (data not shown), so shRNAs can be transcribed successfully from the human and Drosophila U6 promoters in T. ni cells.
Insect cells have been used to express various recombinant proteins using baculovirus expression vector systems [22, 24, 41, 42] . However, the major drawback of this system is that it cannot synthesize the terminally sialylated complextype N-glycans that are produced in mammalian cells. The T. ni cells were transfected with three different types of shRNA plasmid. Forty-eight h after transfection, cells were isolated and the GlcNAcase mRNA levels were analyzed by real-time quantitative RT-PCR. Each result represents the mean ± SD from three independent experiments. Statistically significant differences compared with the control group (*, P < 0.05).
current understanding about the inability of insect cells to produce mammalian type N-glycans can be summarized as follows: (i) lack of an adequate level of glycosyltransferases that are responsible for generating a complex type structure and metabolic enzymes involved in generating essential donor sugar nucleotides; and (ii) the presence of GlcNAcase, which removes a terminal N-acetylglucosamine residue from intermediate N-glycans, leading to the generation of paucimannosidic structures [41, 42] .
In the present study, we carried out the specific knockdown of GlcNAcase using RNA inhibition technology to produce glycoproteins with human-like glycosylation in insect cell baculovirus expression systems. Several studies have shown that the N-glycan processing pathways in insect cells can be extended by the insertion of a mammalian transferase gene encoding functions that are missing or limited relative to mammalian cells [16, 17] . In contrast, little is known about the suppression of intrinsic GlcNAcase activity that enables insect cells to retain the ability to construct complex N-glycans like those in mammalian cells. We applied DNA vector-based strategies for the delivery of siRNA into T. ni cells for GlcNAcase gene silencing. GlcNAcase activity was suppressed by shRNA B to 15% of the level of control vector-treated cells and the suppressions of GlcNAcase were below expectation. Recently, Geisler and Jarvis [13] studied the isolation of the N-acetylglucosaminidases gene (fdl gene) as isoform of GlcNAcase (gene bank number AY078172) that was targeted in our study. The suppression of GlcNAcase was less efficient because there are GlcNAcase isomerases in T. ni cells. Our data demonstrated that shRNA effectively inhibited the expression of the target gene, suggesting that this technique is applicable for producing more mammalianlike recombinant glycoproteins in T. ni cells. Previous works have demonstrated that RNAi efficiency was highly linked to the target position, suggesting the importance of testing various siRNAs [3, 19] . To evaluate this insight, three types of siRNA for GlcNAcase were designed following the eight criteria recently described by Reynolds et al. [36] . The target site B was more effective compared with target sites A or C for the suppression of GlcNAcase mRNA and protein levels ( Fig. 5 and 6 ). It has a difference in that target site B was 5 bases forward than A, and this difference affected the efficiency of GlcNAcase suppression. We suggest that the target sequence is more important in determining the efficiency of target protein suppression than the species origin of the U6 promoter.
In conclusion, the data presented in this study will be useful for applications in T. ni cells targeting the specific knockdown of genes and the development of RNAi-based cell lines for use with the baculovirus expression system. Our results showed that shRNA has the potential to be used for the specific knockdown of GlcNAcase and will be useful for the production of more mammalian-like glycoproteins using the baculovirus expression vector system.
